Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma
Wendi S. Lambert(Vanderbilt University Medical Center), David J. Calkins(Vanderbilt University Medical Center)
Cited by 21
Related Papers
Solving neurodegeneration: common mechanisms and strategies for new treatments
|Molecular Neurodegeneration|2022|297
Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma
|Molecular Neurobiology|2022|33
Towards A Microbead Occlusion Model of Glaucoma for a Non-Human Primate
|Scientific Reports|2019|32
Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
|Frontiers in Neuroscience|2017|30
Neutral sphingomyelinase inhibition promotes local and network degeneration in vitro and in vivo
|Cell Communication and Signaling|2023|20